News
INCR
0.8515
-2.01%
-0.0175
InterCure Moves To Regain Nasdaq Compliance With 1-for-5 Reverse Share Split
NASDAQ · 2d ago
InterCure to effect one-for-five reverse split
TipRanks · 2d ago
Weekly Report: what happened at INCR last week (0810-0814)?
Weekly Report · 4d ago
InterCure Shareholders Approve Proposal at August 11 Extraordinary Meeting
TipRanks · 08/11 13:56
Weekly Report: what happened at INCR last week (0803-0807)?
Weekly Report · 08/10 09:17
Intercure Details Voting Procedures for August 11 Extraordinary Shareholder Meeting
TipRanks · 08/04 13:17
Weekly Report: what happened at INCR last week (0727-0731)?
Weekly Report · 08/03 09:17
Weekly Report: what happened at INCR last week (0720-0724)?
Weekly Report · 07/27 09:18
InterCure Calls August 12 EGM to Approve 5‑for‑1 Reverse Share Split
TipRanks · 07/22 20:29
Weekly Report: what happened at INCR last week (0713-0717)?
Weekly Report · 07/20 09:17
Weekly Report: what happened at INCR last week (0706-0710)?
Weekly Report · 07/13 09:18
Weekly Report: what happened at INCR last week (0629-0703)?
Weekly Report · 07/06 09:19
Weekly Report: what happened at INCR last week (0622-0626)?
Weekly Report · 06/29 09:18
InterCure Secures NIS 22 Million In Private Placement Financing
NASDAQ · 06/23 07:40
InterCure Secures NIS 22 Million Private Placement to Fund Global Medical Cannabis Expansion
TipRanks · 06/22 13:42
InterCure secures up to NIS 54M financing
Seeking Alpha · 06/22 13:03
InterCure Enters Private Placement With Its CEO And Other Shareholders For Commitments Of ~$7.4M, With Option To Increase To ~$18.6M
Benzinga · 06/22 12:54
Weekly Report: what happened at INCR last week (0615-0619)?
Weekly Report · 06/22 09:20
InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds
Barchart · 06/22 07:50
InterCure Advances Global Push With Botanico Acquisition Tranche and U.S. Strategy Review
TipRanks · 06/15 14:03
More
Webull provides a variety of real-time INCR stock news. You can receive the latest news about Intercure Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About INCR
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.